Background: Dengue is one of the most common infection in the tropical countries. Comorbidities, especially Diabetes is known to influence the outcome of patients with Dengue fever. Objectives: To study the clinical profile of patients with dengue and to identify the role of Diabetes mellitus in the development of sever dengue. Methods: Observational study on 342 patients admitted with a diagnosis of Dengue fever. Patients were admitted and managed as per the institutional protocol. The patients were studied during the entire hospital stay and was observed for the development of complications like hemorrhage or shock. The differences in occurrence of complications among diabetics and non diabetics were compared. Results: Complications like Dengue Hemorrhagic fever, Shock and mortality were high among diabetics when compared to non diabetics. Conclusions: Diabetic patients admitted with dengue requires more vigilant monitoring for development of complications.
Background
Dengue is an important mosquito borne disease in the tropical and subtropical regions. Dengue fever is often clinically self limited and presents with fever, arthralgia, myalgia and head ache. Dengue hemorrhagic fever is characterized by thrombocytopenia, hemorrhage and plasma leak resulting from increased vascular permeability (1, 2) . Dengue shock syndrome has a mortality of as high as 20% (3) (4) (5) . Co-morbidities were reported to aggravate dengue illness, suggesting host characteristics risk factors in the development of Dengue Hemorrhagic fever/ Dengue Shock Syndrome (6) (7) (8) (9) . Diabetes Mellitus. a globally highly prevalent disease, is one of the note worthy proposed host risk factors for the development of Dengue Hemorrhagic Fever/Dengue Shock Syndrome/ Severe Dengue, although conflicting results were found in some researches; this is not surprising as Diabetes is a multifaceted disease that implicates a wide range of metabolic derangements and immune dysfunction.
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The objectives of the study were to identify the role of Diabetes Mellitus as a risk for the development of serious forms of Dengue, emphasizing the role of blood sugar control. The patients will be hospitalized according to the institutional protocol and managed as per the WHO guidelines. Patients will be monitored clinically for the development of Dengue Shock Syndrome/ Dengue Hemorrhagic Fever. Daily CBC will be measured for the evidence of hemoconcentration. Patients will be followed up till the end of their hospital stay with the outcome measured as either died or survived. After data collection, an attempt will be made to find out the effect of Diabetes mellitus, either pre existing or newly detected Diabetes, in the development of complications and the final outcome. There was significant relation between the presence of diabetes (either newly detected or pre existing) between hemoconcentration, serositis, time for platelet recovery and outcome. There was no significant association between diabetes and bleeding manifestations (p value 1.000) The study could also not establish any significant relation between diabetes and the platelet count at the time of admission(p value 0.566) or the total WBC count at the time of admission(p value 0.424). There was no significant relation between the glycemic control as expressed by the HbA1c and the presence of bleeding manifestations (p value 1.000). There was also no significant relation between the presence of diabetes or diabetic control with the development of pericardial effusion. The study could also not establish any significant relation between diabetic control and the final outcome (p value 1.000) This study could not find any significant relation metformin use with bleeding manifestations, outcome or capillary leak.
Definitions

Discussion
The study population included 342 cases, who satisfied the WHO case definition of Dengue. In our study population, 62.3% were males and 37.7% were females. Of the 342 cases, 2 individuals with dengue shock syndrome expired. 99.1% cases survived and were successfully discharged. It was seen that Diabetes, new onset or pre existing, was associated with an increased mortality, time taken for platelet recovery, capillary leak. However, no significant association was seen with the use of metformin and protective effect in dengue, as opposed to previous studies (10) No significant association was observed between Diabetes and the total count or platelet count at the time of admission
Conclusion
Diabetes, pre existing or newly diagnosed, is significantly associated with mortality and complications, in patients admitted with Dengue.
